High-throughput genotyping of high-risk HPV by the digene HPV Genotyping LQ Test using GP5+/6+-PCR and xMAP technology

Journal of Clinical Virology

Volumn 46, Issue SUPPL. 3, 2009, Pages

  Geraets, D T ^a   Heideman, D A M ^b   de Koning, M N C ^a   Snijders, P J F ^b   van Alewijk, D C J G ^a   Meijer, C J L M ^b   van Doorn, L J ^a   Quint, W G V ^a  

^a DDL DIAGNOSTIC LABORATORY   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Genotyping; GP5+ 6+ PCR; Human papillomavirus; Hybrid Capture 2; Luminex xMAP; Reverse Line Blot

Indexed keywords

ARTICLE; ASSAY; CONTROLLED STUDY; DIGENE HPV GENOTYPING LQ TEST; DNA MICROARRAY; FEMALE; GENOTYPE; HIGH RISK POPULATION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 18; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPRODUCIBILITY; REVERSE LINE BLOT GENOTYPING ASSAY; SCREENING TEST; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

ALPHAPAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; GENES, VIRAL; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MASS SCREENING; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; RISK; SENSITIVITY AND SPECIFICITY; SPECIES SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 72249104021     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(09)70297-5     Document Type: Article

References (14)

1. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 6 (2003) 518-527
2. Meijer C.J., Berkhof J., Castle P.E., Hesselink A.T., Franco E.L., Ronco G., et al. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer 124 3 (2009) 516-520
3. van den Brule A.J., Pol R., Fransen-Daalmeijer N., Schouls L.M., Meijer C.J., and Snijders P.J. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 40 3 (2002) 779-787
4. Khan M.J., Castle P.E., Lorincz A.T., Wacholder S., Sherman M., Scott D.R., et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 97 14 (2005) 1072-1079
5. Berkhof J., Bulkmans N.W., Bleeker M.C., Bulk S., Snijders P.J., Voorhorst F.J., et al. Human papillomavirus type-specific 18-month risk of high-grade cervical intraepithelial neoplasia in women with a normal or borderline/mildly dyskaryotic smear. Cancer Epidemiol Biomarkers Prev 15 7 (2006) 1268-1273
6. Bulkmans N.W., Berkhof J., Bulk S., Bleeker M.C., van Kemenade F.J., Rozendaal L., et al. High-risk HPV type-specific clearance rates in cervical screening. Br J Cancer 96 9 (2007) 1419-1424
7. Meijer C.J., Snijders P.J., and Castle P.E. Clinical utility of HPV genotyping. Gynecol Oncol 103 1 (2006) 12-17
8. Hesselink A.T., Bulkmans N.W., Berkhof J., Lorincz A.T., Meijer C.J., and Snijders P.J. Cross-sectional comparison of an automated Hybrid Capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program. J Clin Microbiol 44 10 (2006) 3680-3685
9. Geraets D.T., Heideman D., de Koning M.N.C., Snijders P.J.F., Meijer C.J.L.M., van Doorn L.J., et al. High genotyping concordance between the digene HPV Genotyping RH Test and the Reverse Line Blot genotyping assay on GP5+/6+-PCR products. J Clin Virol 46 Suppl 3 (2009) S16-S20
10. Hesselink A.T., van Ham M.A., Heideman D.A., Groothuismink Z.M., Rozendaal L., Berkhof J., et al. Comparison of GP5+/6+-PCR and SPF10-line blot assays for detection of high-risk human papillomavirus in samples from women with normal cytology results who develop grade 3 cervical intraepithelial neoplasia. J Clin Microbiol 46 10 (2008) 3215-3221
11. van Doorn L.J., Quint W., Kleter B., Molijn A., Colau B., Martin M.T., et al. Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY Line Blot Assay and the SPF10 Line Probe Assay. J Clin Microbiol 40 3 (2002) 979-983
12. Peyton C.L., Schiffman M., Lorincz A.T., Hunt W.C., Mielzynska I., Bratti C., et al. Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol 36 11 (1998) 3248-3254
13. Poljak M., Marin I.J., Seme K., and Vince A. Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail. J Clin Virol 25 Suppl 3 (2002) S89-S97
14. Castle P.E., Solomon D., Wheeler C.M., Gravitt P.E., Wacholder S., and Schiffman M. Human papillomavirus genotype specificity of Hybrid Capture 2. J Clin Microbiol 46 8 (2008) 2595-2604